Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fragment-type 4-azolylcoumarin derivatives with anticancer properties.
Simic M, Petkovic M, Jovanovic P, Jovanovic M, Tasic G, Besu I, Zizak Z, Aleksic I, Nikodinovic-Runic J, Savic V. Simic M, et al. Among authors: besu i. Arch Pharm (Weinheim). 2021 Nov;354(11):e2100238. doi: 10.1002/ardp.202100238. Epub 2021 Aug 10. Arch Pharm (Weinheim). 2021. PMID: 34374111
Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients.
Stanojković TP, Matić IZ, Petrović N, Stanković V, Kopčalić K, Besu I, Đorđić Crnogorac M, Mališić E, Mirjačić-Martinović K, Vuletić A, Bukumirić Z, Žižak Ž, Veldwijk M, Herskind C, Nikitović M. Stanojković TP, et al. Among authors: besu i. Sci Rep. 2020 Nov 4;10(1):19002. doi: 10.1038/s41598-020-75812-0. Sci Rep. 2020. PMID: 33149212 Free PMC article.
Immunoreactivity to food antigens in patients with chronic urticaria.
Rašković S, Matić IZ, Dorđić M, Damjanović A, Kolundžija B, Grozdanić-Stanisavljević N, Besu I, Jovičić Z, Bijelić B, Janković L, Juranić Z. Rašković S, et al. Among authors: besu i. Immunol Invest. 2014;43(5):504-16. doi: 10.3109/08820139.2014.892509. Epub 2014 Mar 24. Immunol Invest. 2014. PMID: 24661189
Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.
Jevrić M, Matić IZ, Krivokuća A, Đorđić Crnogorac M, Besu I, Damjanović A, Branković-Magić M, Milovanović Z, Gavrilović D, Susnjar S, Kisić Tepavčević D, Stanojković T. Jevrić M, et al. Among authors: besu i. BMC Cancer. 2019 Jan 15;19(1):71. doi: 10.1186/s12885-018-5255-z. BMC Cancer. 2019. PMID: 30646864 Free PMC article.
15 results